SEC 13F Intelligence

Abrams Capital Management, L.P. / BMY-R

Abrams Capital Management, L.P.’s Bristol-Myers Squibb Contingen Position

Does Abrams Capital Management, L.P. own Bristol-Myers Squibb Contingen (BMY-R)? Not currently — the last reported position was 24.80M shares worth $17M in Q4 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$17M
Q4 2020
Shares
24.80M
% of Portfolio
+0.48%
Quarters Held
5
position exited

Position History BMY-R

Reported value by quarter
Q4 ’19: $70MQ4 ’19Q1 ’20: $88MQ1 ’20Q2 ’20: $83MQ2 ’20Q3 ’20: $33MQ3 ’20Q4 ’20: $17MQ4 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202024.80M$17M+0.48%
Q3 202014.80M$33M+1.05%
Q2 202023.20M$83M+2.68%
Q1 202023.20M$88M+3.47%
Q4 201923.20M$70M+2.17%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Abrams Capital Management, L.P.’s full portfolio or all institutional holders of BMY-R.